Key Record Dates
| ClinicalTrials.gov Identifier: | NCT01136733 |
|---|---|
| Brief Title: | A Study of E7080 Alone, and in Combination With Everolimus in Subjects With Unresectable Advanced or Metastatic Renal Cell Carcinoma Following One Prior Vascular Endothelial Growth Factor (VEGF)-Targeted Treatment |
| First Submitted : | May 26, 2010 |
| First Submitted that Met QC Criteria : | June 2, 2010 |
| First Posted : | June 3, 2010 (Estimate) |
| Results First Submitted : | November 23, 2016 |
| Results First Submitted that Met QC Criteria : | February 7, 2019 |
| Results First Posted : | February 27, 2019 |
| Certification/Extension First Submitted : | April 18, 2016 |
| Certification/Extension First Submitted that Met QC Criteria : | April 18, 2016 |
| Certification/Extension First Posted : | May 17, 2016 (Estimate) |
| Last Update Submitted that Met QC Criteria : | February 7, 2019 |
| Last Update Posted : | February 27, 2019 |